These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 28233153)

  • 21. Long-acting β2-agonist step-off in patients with controlled asthma.
    Brozek JL; Kraft M; Krishnan JA; Cloutier MM; Lazarus SC; Li JT; Santesso N; Strunk RC; Casale TB
    Arch Intern Med; 2012 Oct; 172(18):1365-75. PubMed ID: 22928176
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimizing maintenance therapy in pediatric asthma.
    Farber HJ
    Curr Opin Pulm Med; 2010 Jan; 16(1):25-30. PubMed ID: 19904206
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Corticosteroid treatment in airways narrowing].
    Chazan R
    Pneumonol Alergol Pol; 2008; 76(2):96-100. PubMed ID: 18464224
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phenotypes and endotypes of uncontrolled severe asthma: new treatments.
    Campo P; Rodríguez F; Sánchez-García S; Barranco P; Quirce S; Pérez-Francés C; Gómez-Torrijos E; Cárdenas R; Olaguibel JM; Delgado J; ;
    J Investig Allergol Clin Immunol; 2013; 23(2):76-88; quiz 1 p. follow 88. PubMed ID: 23654073
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β
    Bleecker ER; FitzGerald JM; Chanez P; Papi A; Weinstein SF; Barker P; Sproule S; Gilmartin G; Aurivillius M; Werkström V; Goldman M;
    Lancet; 2016 Oct; 388(10056):2115-2127. PubMed ID: 27609408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative efficacy of inhaled corticosteroids and antileukotriene drugs in asthma.
    Smith LJ
    BioDrugs; 2001; 15(4):239-49. PubMed ID: 11437689
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic approaches to asthma-chronic obstructive pulmonary disease overlap syndromes.
    Barnes PJ
    J Allergy Clin Immunol; 2015 Sep; 136(3):531-45. PubMed ID: 26343937
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New and developing non-adrenoreceptor small molecule drugs for the treatment of asthma.
    Thomson NC
    Expert Opin Pharmacother; 2017 Feb; 18(3):283-293. PubMed ID: 28099820
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adapting clinical trial design to maintain meaningful outcomes during a multicenter asthma trial in the precision medicine era.
    Sorkness CA; King TS; Dyer AM; Chinchilli VM; Mauger DT; Krishnan JA; Blake K; Castro M; Covar R; Israel E; Kraft M; Lang JE; Lugogo N; Peters SP; Wechsler ME; Wenzel SE; Lazarus SC;
    Contemp Clin Trials; 2019 Feb; 77():98-103. PubMed ID: 30593883
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness of drug treatment strategies to prevent asthma exacerbations and increase symptom-free days in asthmatic children: a network meta-analysis.
    Zhao Y; Han S; Shang J; Zhao X; Pu R; Shi L
    J Asthma; 2015 Oct; 52(8):846-57. PubMed ID: 26061910
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Budesonide/formoterol maintenance and reliever therapy. A new treatment approach for adult patients with asthma].
    Korn S; Vogelmeier C; Buhl R
    Med Klin (Munich); 2008 May; 103(5):299-310. PubMed ID: 18484216
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Omalizumab: an update on efficacy and safety in moderate-to-severe allergic asthma.
    Chipps BE; Figliomeni M; Spector S
    Allergy Asthma Proc; 2012; 33(5):377-85. PubMed ID: 23026179
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The management of severe asthma in 2020.
    Côté A; Godbout K; Boulet LP
    Biochem Pharmacol; 2020 Sep; 179():114112. PubMed ID: 32598948
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characteristics, phenotypes, mechanisms and management of severe asthma.
    Chung KF; Dixey P; Abubakar-Waziri H; Bhavsar P; Patel PH; Guo S; Ji Y
    Chin Med J (Engl); 2022 May; 135(10):1141-1155. PubMed ID: 35633594
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Severe asthma: advances in current management and future therapy.
    Barnes PJ
    J Allergy Clin Immunol; 2012 Jan; 129(1):48-59. PubMed ID: 22196524
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Zafirlukast improves asthma control in patients receiving high-dose inhaled corticosteroids.
    Virchow JC; Prasse A; Naya I; Summerton L; Harris A
    Am J Respir Crit Care Med; 2000 Aug; 162(2 Pt 1):578-85. PubMed ID: 10934090
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Current Asthma Treatment in Light of New Asthma Guidelines].
    Lommatzsch M
    Dtsch Med Wochenschr; 2018 Jun; 143(11):806-810. PubMed ID: 29807381
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Severe asthma in adults].
    Weersink EJ; Braunstahl GJ; Roldaan AC
    Ned Tijdschr Geneeskd; 2013; 157(19):A6232. PubMed ID: 23657105
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medications and Recent Patents for Status Asthmaticus in Children.
    Hon KLE; Leung AKC
    Recent Pat Inflamm Allergy Drug Discov; 2017; 11(1):12-21. PubMed ID: 28137226
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Precision medicine in asthma: linking phenotypes to targeted treatments.
    Chung KF
    Curr Opin Pulm Med; 2018 Jan; 24(1):4-10. PubMed ID: 29036018
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.